B. Nieuweboer

465 total citations
27 papers, 375 citations indexed

About

B. Nieuweboer is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, B. Nieuweboer has authored 27 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in B. Nieuweboer's work include Radiopharmaceutical Chemistry and Applications (6 papers), Hormonal and reproductive studies (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). B. Nieuweboer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Hormonal and reproductive studies (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). B. Nieuweboer collaborates with scholars based in Germany, Sweden and Italy. B. Nieuweboer's co-authors include M. Hümpel, H. Wendt, W. Kŕause, Ulrich Speck, Syed Hadi Hasan, Michael S. Hildebrand, Paul Schülze, U. Täuber, Jan Tack and R. Dorow and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology and Contraception.

In The Last Decade

B. Nieuweboer

26 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Nieuweboer Germany 13 100 59 53 51 49 27 375
B. Brooks Israel 12 41 0.4× 40 0.7× 21 0.4× 109 2.1× 21 0.4× 20 363
Gerrit Voortman Netherlands 16 82 0.8× 179 3.0× 126 2.4× 106 2.1× 76 1.6× 26 695
B Catanese Italy 14 20 0.2× 30 0.5× 105 2.0× 139 2.7× 76 1.6× 50 474
C. R. Jones United Kingdom 13 28 0.3× 117 2.0× 27 0.5× 222 4.4× 27 0.6× 27 549
R. A. Yates United Kingdom 14 46 0.5× 13 0.2× 135 2.5× 104 2.0× 48 1.0× 27 630
Jerome R. Bagley United States 13 30 0.3× 13 0.2× 63 1.2× 194 3.8× 67 1.4× 31 613
F. M. Sturtevant United States 13 111 1.1× 43 0.7× 10 0.2× 76 1.5× 22 0.4× 37 420
Rui Peng China 12 76 0.8× 20 0.3× 26 0.5× 72 1.4× 24 0.5× 42 372
Michael Shalmi Denmark 13 133 1.3× 21 0.4× 49 0.9× 224 4.4× 37 0.8× 39 530
K. F. Stöa Norway 14 160 1.6× 22 0.4× 20 0.4× 89 1.7× 21 0.4× 47 518

Countries citing papers authored by B. Nieuweboer

Since Specialization
Citations

This map shows the geographic impact of B. Nieuweboer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Nieuweboer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Nieuweboer more than expected).

Fields of papers citing papers by B. Nieuweboer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Nieuweboer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Nieuweboer. The network helps show where B. Nieuweboer may publish in the future.

Co-authorship network of co-authors of B. Nieuweboer

This figure shows the co-authorship network connecting the top 25 collaborators of B. Nieuweboer. A scholar is included among the top collaborators of B. Nieuweboer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Nieuweboer. B. Nieuweboer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hildebrand, Michael S. & B. Nieuweboer. (1994). Development and Validation of a Sensitive and Specific Radioimmunoassay for the Determination of Cicaprost in Biological Samples. Journal of Immunoassay. 15(2). 171–190. 2 indexed citations
2.
Hildebrand, Michael S., T Staks, & B. Nieuweboer. (1990). Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 ?G. European Journal of Clinical Pharmacology. 39(2). 149–153. 13 indexed citations
3.
Stürzebecher, S, et al.. (1989). Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.. PubMed. 301. 365–9. 5 indexed citations
4.
Nieuweboer, B., Jan Tack, U. Täuber, M. Hümpel, & H. Wendt. (1989). Development and application of a radioimmunoassay of the new progestagen gestodene. Contraception. 40(3). 313–323. 26 indexed citations
5.
Li, Qigui & B. Nieuweboer. (1989). Radioimmunological determination of levonorgestrel and ethinylestradiol. Journal of Tongji Medical University. 9(2). 65–73. 6 indexed citations
6.
Kŕause, W., et al.. (1988). Pharmacokinetics of lisuride after subcutaneous infusion. PubMed. 27. 71–74. 2 indexed citations
7.
Luquín, M. R., et al.. (1987). Parenteral administration of lisuride in Parkinson's disease.. PubMed. 45. 561–8. 8 indexed citations
8.
Kŕause, W., et al.. (1985). Development of antibody — mediated extraction followed by GC/MS (antibody/GC/MS) and its application to iloprost determination in plasma. Prostaglandins Leukotrienes and Medicine. 17(2). 167–182. 33 indexed citations
9.
Kŕause, W. & B. Nieuweboer. (1984). Development of a radioimmunoassay and its application to the pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat. Prostaglandins Leukotrienes and Medicine. 14(1). 1–9. 2 indexed citations
10.
Kŕause, W., R. Dorow, B. Nieuweboer, & Syed Hadi Hasan. (1984). Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man. European Journal of Clinical Pharmacology. 27(3). 335–339. 11 indexed citations
11.
12.
Nieuweboer, B., et al.. (1982). A highly specific radioimmunological determination of sulprostone using antisera against two different haptens. Prostaglandins Leukotrienes and Medicine. 9(2). 183–191. 4 indexed citations
13.
Bhargava, Akhil, et al.. (1981). Effect of cyproterone acetate and its metabolites on the adrenal function in man, rhesus monkey and rat.. PubMed. 31(6). 1005–9. 1 indexed citations
14.
Hümpel, M., et al.. (1980). Kinetics and biotransformation of lormetazepam. Clinical Pharmacology & Therapeutics. 28(5). 673–679. 46 indexed citations
15.
Hümpel, M., B. Nieuweboer, H. Wendt, & Ulrich Speck. (1979). Investigations of pharmacokinetics of ethinyloestradiol to specific consideration of a possible first-pass effect in women. Contraception. 19(4). 421–432. 52 indexed citations
16.
Nieuweboer, B., et al.. (1977). Radioimmunological Determination of Cyproterone Acetate. Hormone Research. 8(4). 210–218. 26 indexed citations
17.
18.
Nieuweboer, B., et al.. (1971). [The metabolism of norethisterone (17 -ethinyl-4-estren-17 -ol-3-one) and of DL- and D-norgestrel (18-methyl-17 -ethinyl-4-estren-17 -ol-3-one) in man. (Alkyl-substituted steroids. 8)].. PubMed. 68(2). 219–48. 35 indexed citations
19.
Nieuweboer, B., et al.. (1971). [Metabolism of 6 -fluor-16 -methylpregna-1,4-dien-ll ,21-diol-3,20-dion (fluocortolone) in man. Isolation of 6 -hydroxylated metabolites (alkyl-substituted steroids VII)].. PubMed. 68(1). 98–126. 15 indexed citations
20.
Nieuweboer, B., et al.. (1969). [On the alkyl-substituted steroids. V. Testosterone excretion in man after oral administration of 1alpha-methyl-5alpha-androstane-17beta ol-3-one(mesterolone) and 17-alpha-methyl-androst-4-en-17beta-ol-3-one (17 alpha-methyltestosterone)].. PubMed. 19(5). 765–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Brooks Breakdown of academic impact, for papers by Gerrit Voortman Breakdown of academic impact, for papers by B Catanese Breakdown of academic impact, for papers by C. R. Jones Breakdown of academic impact, for papers by R. A. Yates Breakdown of academic impact, for papers by Jerome R. Bagley Breakdown of academic impact, for papers by F. M. Sturtevant Breakdown of academic impact, for papers by Rui Peng Breakdown of academic impact, for papers by Michael Shalmi Breakdown of academic impact, for papers by K. F. Stöa
Rankless by CCL
2026